Follow-The-Filings

Security · featured owners

CNTX Context Therapeutics Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.4%
  • $3M

CNTX (Context Therapeutics Inc.) is held in 1 featured 13F book as of 2026 Q2. David Witzke - Avidity Partners Management is the largest tracked holder by portfolio weight (0.44%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.4% (David Witzke - Avidity Partners Management) · not free-float ownership

  1. David Witzke 0.44%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
David Witzke - Avidity Partners Management 2026 Q2 0.44% Hold 4,998,267 $3M history

1 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 23 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
10-Q Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 3.01 Filing Doc
8-K 5.03,5.07,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 1.01,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 8.01 Filing Doc
DEFA14A Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
10-K Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 5.03,8.01,9.01 Filing Doc
8-K 8.01 Filing Doc
8-K 7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
424B5 Filing Doc
8-K 1.01,8.01,9.01 Filing Doc
8-K 8.01 Filing Doc
8-K 3.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 4 rows shown

Filed Form Detail Links
4 Period Jun 24, 2026 · 6 forms Filing Doc
4 Period Feb 19, 2026 · 4 forms Filing Doc
4 Period Jun 12, 2025 · 6 forms Filing Doc
4 Period Jun 9, 2025 Filing Doc

Updated 6 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Net income -$23.96M -$26.73M -$36.12M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $16.05M $97.9M $68.35M
Total non-current assets * $15,524 $230,775 $140,066
Total assets $16.06M $98.13M $68.49M
Total current liabilities $4.19M $2.75M $8.02M
Total non-current liabilities * $0.00 $112,064 $0.00
Total equity $11.87M $95.27M $60.47M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$21.05M -$14.56M -$26.39M
Cash from investing $0M -$14.76M -$2.03M
Cash from financing $0M $109.29M -$0.015M
Net change in cash -$21.05M $79.98M -$28.43M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders